Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
about
Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restrictionLipid Lowering Therapy and Circulating PCSK9 Concentration.Pharmacological management of diabetic dyslipidemia.Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.
P2860
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Correlation between serum leve ...... s with coronary artery disease
@en
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9
@nl
type
label
Correlation between serum leve ...... s with coronary artery disease
@en
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9
@nl
prefLabel
Correlation between serum leve ...... s with coronary artery disease
@en
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9
@nl
P2093
P2860
P1476
Correlation between serum leve ...... s with coronary artery disease
@en
P2093
Hiroaki Hattori
Ichiro Michishita
Kazuyuki Ogawa
Tadao Iwasaki
Takeshi Kujiraoka
Tsutomu Hirano
Tsuyoshi Nozue
P2860
P2888
P356
10.1186/S12944-016-0339-8
P577
2016-09-22T00:00:00Z
P6179
1046753598